drugset / Trial / NCT06649864
Adipose-Derived Mesenchymal Stem Cell for Preventing Biliary Complications
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the safety of autologous Adipose-Derived Mesenchymal Stem Cell for use in End-Stage Liver Disease patients undergoing the creation of a duct-to-duct anastomosis during Living Donor Liver Transplantation.
Timeline
- Start
- 2027-02
- Primary completion
- 2028-01
- Completion
- 2028-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adipose derived mesenchymal stromal cells | Cell therapy | 3e+06 cells | Other |
| Subject | Adipose derived mesenchymal stromal cells | Cell therapy | 5e+06 cells | Other |